Wikipedia -WSS

Wikipedia

author：fashion 2025-09-28 00:51:42 - browse：764

Illustration of researchers working among oversized pill bottles, lab equipment, and medicine for story about the development of obesity medications – health and pharma coverage from STAT — Molly Ferguson for STAT

The exploding popularity of drugs like Wegovy and Mounjaro has propelled dozens of companies to develop their own obesity treatments, with most of them trying to emulate the same approach as the blockbuster products.

Nearly 70 obesity treatments are in development, and about two-thirds use a similar mechanism as Wegovy and Mounjaro, according to the STAT Obesity Drug Tracker, a new database compiled by STAT. There are also a minority of companies pursuing entirely different approaches, hoping that they will stand out among the field.

The tracker, which will be updated with significant developments each quarter, gives a sense of what new mechanisms could hit the market, how they would be delivered, and which companies are running the most trials.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Bright Health sells Medicare Advantage business to Molina
Next article： Elisabeth Bik tackles the widespread issue of research misconduct

entertainment

WSS

5 ways to address the shortage of health care workers

Redefining sustainability for the pharmaceutical industry

More tobacco lobbyists active in statehouses

Cancer researcher Catriona Jamieson is sending tumors into space

MassMutual is introducing free genetic testing for members

Element Biosciences CEO lays out genome sequencing strategy

focus

Wikipedia

focus

Biden outlines 'new path' to provide student loan relief after Supreme Court rejection

STAT Madness 2024: Meet the contenders

Moonlake's readout produced a cash windfall. Risks remain

UnitedHealth financials solid despite Change Healthcare cyberattack

United colonoscopy coverage change 'may cost lives,' doctors say

There should be a 'Moonshot' or 'Warp Speed' for rare diseases

Walensky prepares to leave CDC — and Congress — behind

Laying a path for careers in science

Biden outlines 'new path' to provide student loan relief after Supreme Court rejection

Cholera vaccine supplies dangerously low, outbreaks surging

hotspot

FTC falls short on scrutinizing hospital mergers, study says

STAT Madness 2024: Meet the contenders

Medicare isn't yet testing food as medicine

Close Medicare's dangerous gaps in addiction treatment coverage

Are embryos people? Reproductive medicine's future depends on the answer

Children’s Hospital revives plan for pedestrian bridge

entertainment

focus

entertainment

explore